MPMona Piplani

Mona Piplani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mona Piplani has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Translating Molecular Pathogenesis into Therapeutics: Emerging Strategies and Clinical Prospects for Alzheimer’s Disease

    by Mona Piplani, Shivani Thakur, Pankaj Kumar, Sourbh Suren Garg, Ankush Goyal, Pradeep Goyal

    Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that affects millions of people worldwide and poses a major global health challenge. This complex disease involves multiple pathogenic factors, including amyloid-beta (Aβ), tau protein aggregation, synaptic dysfunction, mitochondrial impairment, oxidative stress, and genetic influences. While the intricate interplay and individual contributions of these elements to AD progression remain under investigation, considerable advancements have been made in elucidating their roles. This review examines the molecular mechanisms underlying the pathogenesis of AD, highlighting how each factor contributes to the onset and progression of the disorder. To date, significant efforts in AD research have focused on diverse therapeutic approaches, including targeting Aβ and tau proteins, modulating neuroinflammation, enhancing autophagy, and restoring synaptic function. As these strategies evolve, they provide renewed hope for interventions that could slow AD progression and improve cognitive function. Furthermore, a multi-targeted approach addressing these interconnected pathways shows promise for managing the complex pathology of AD. Continued research in these areas will be essential for identifying novel therapeutic options and advancing clinical strategies for AD management.

  • Open Access

    A Comprehensive Review on Nephroprotective Activity of the Potential of Indian Traditional Medicinal Plants

    by Mudit Kumar, Pushpendra Kumar, Mona Piplani

    Because they control waste elimination, electrolyte composition, and fluid balance, kidneys are essential for preserving homeostasis. Acute and chronic kidney illnesses are largely caused by exposure to nephrotoxic substances, including medicines, environmental pollutants, and metabolic abnormalities. With a growing reliance on dialysis and a scarcity of kidney transplants, the prevalence of chronic kidney disease (CKD) is rapidly increasing both globally and in India. Despite their effectiveness, conventional treatments can have negative side effects and are expensive. Because of their long history of traditional use, affordability, and safety, herbal and plant-based medicines are gaining popularity. This review thoroughly identifies medicinal plants that have been shown to have nephroprotective potential against kidney damage caused by drugs and toxins. Antioxidant, anti-inflammatory, and free radical scavenging mechanisms are the main ways that plants like Allium sativum, Aloe vera, Azadirachta indica, Curcuma longa, Ginkgo biloba, Withania somnifera, and several others have nephroprotective benefits. Flavonoids, alkaloids, saponins, polyphenols, terpenoids, and glycosides are among the phytoconstituents that are accountable. The function of these medicinal herbs in maintaining renal structure and function is firmly supported by experimental and preclinical data. This study highlights the therapeutic potential of nephroprotective plants and encourages more research into them in order to create safer and more potent renal protective medicines.

  • Thiolated chitosan as an improved bioadhesive polymer in drug delivery

    by Shailja Jain, Kshitij Nuwal, Arisha Mahmood, Mona Piplani, Subhash Chander, Sunil Kumar Dubey, Gautam Singhvi


  • Recent Advances in Colon Drug Delivery Technology

    by Rakesh Pahwa, Ridhi Bajaj, Pankaj Bhateja, Mona Piplani

    Colon-targeted drug delivery technology; an approach of immense potential, has acquired tremendous significance for managing a number of ailments, particularly of the colon and for delivering therapeutic proteins and peptides systemically. The major hurdles for delivering drugs in the colonic region include absorption and degradation pathways in the upper gastrointestinal tract (GIT). To achieve a triumphant colonic delivery, the therapeutic agent must be protected from getting absorbed in the preliminary region of GIT to ensure its release in the proximal colon in a controlled way. The principle approaches, for instance, prodrug approach, pH sensitivity, timedependency (lag time), degradation by microbes, etc. have been effectively applied for obtaining colon targeted drug delivery. These approaches have accomplished immense relevance. Therefore, incessant attempts have been mainly focused on the design of colon targeted drug delivery systems having enhanced site-specificity along with the study of its versatile drug release kinetics to achieve diverse therapeutic requirements. The current manuscript illustrates the significance of different colon drug delivery systems and general considerations for designing colon targeting systems, including primary as well as novel approaches. Recent investigational studies carried out by scientific communities worldwide for the designing and preparation of various colon-targeted formulations along with their significant insights have been described. Recent patents, structure-property relationship and dissolution aspects pertaining to the colon-specific drug delivery have also been depicted.


  • Open Access

    Prodrugs of Antiinfective Agents: A Review

    by Mona Piplani, Avtar Chand Rana, Prabodh Chander Sharma

    Prodrugs are the pharmacologically inactive derivatives of active drugs typically intended to optimize the exposure of active drug at target site, through manipulation of its physicochemical, biopharmaceutical or pharmacokinetic properties. This approach has a number of advantages over conventional drug administration. Antiinfective agents are associated with number of limitations, responsible for their reduced bioavailability. Various antiinfective prodrugs have been synthesized with reduced side effects and improved pharmacological properties. The present paper illustrates different vistas of prodrug approach of antiinfective agents describing brief classification, synthetic approaches, pharmacological aspects and recent patents. It is a very productive area of research and its prologue in human therapy has given triumphant outcomes in improving the clinical and therapeutic effectiveness of drugs.This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.


  • An Insight into Patents of Fluoroquinolone Derivatives

    by Prabodh Chander Sharma, Mona Piplani, Harish Rajak

    Fluoroquinolones are well known and among most promising nitrogen containing heterocyclic compounds depicting broad spectrum and potent anti-infective activities. Numerous fluoroquinolone derivatives have been found to possess considerable favorable properties such as excellent bioavailability, good tissue penetrability and low toxic effects which attract the extensive research endeavors worldwide. With a better understanding of structure activity relationships of fluoroquinolones, it has been possible to develop superior compounds. This paper is an attempt to review the recent patents on these drugs with special emphasis on ciprofloxacin, norfloxacin, ofloxacin and moxifloxacin.

  • Insight View on Possible Role of Fluoroquinolones in Cancer Therapy

    by Prabodh C. Sharma, Monika Chaudhary, Archana Sharma, Mona Piplani, Harish Rajak, Om Prakash

    Cancer is a disease without limits turning out to be prime cause for raising death toll around the world. Several treatment strategies including chemotherapy, surgery and radiotherapy are being employed worldwide to combat this disease. Due to the unwanted effects of currently available therapies, scientific community is immensely interested in exploring newer alternative pathways. Fluoroquinolones have been employed as potent anti-microbial agents for last few decades and now being looked up as potential therapeutic agents in the other ailments also. Several research endeavours are carried out in different parts of the world to focus on the prospective role of fluoroquinolones in carcinogenesis and mutagenesis. This article is an earnest attempt to present recent research work carried out on fluoroquinolones in the context to cancer treatment therapies.